Gene · 4210
Papers4,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ever-expanding role of IFI16 in the anti-viral innate immune response. | Immunol Lett | 2026 | 41547462 | PubTator, text mining | PubMed |
| Evaluation of the Effect of IL-1 Antagonists on Pituitary Function. | Int J Endocrinol | 2026 | 41531813 | PubTator, text mining | PubMed |
| Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients? | Scand J Rheumatol | 2026 | 41527748 | PubTator, text mining | PubMed |
| Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency. | Clin Rheumatol | 2026 | 41518583 | PubTator, text mining | PubMed |
| Association of HLA-B alleles with familial mediterranean fever (FMF): A comparative study. | Immunol Res | 2026 | 41507402 | PubTator, text mining | PubMed |
| Colchicine prophylaxis in pediatric PFAPA: a systematic review. | Eur J Pediatr | 2026 | 41495479 | PubTator, text mining | PubMed |
| Effectiveness of Adjunctive Colchicine for Crohn's Disease with Heterozygous MEFV E148Q Variant. | Indian J Pediatr | 2026 | 41483401 | PubTator, text mining | PubMed |
| Familial Mediterranean Fever: A Comprehensive Review of Pathogenesis, Genetics, and Epigenetic Regulation. | Balkan Med J | 2026 | 41480953 | PubTator, text mining | PubMed |
| Impact of Mediterranean Fever Gene Mutations on Clinical Characteristics in Patients With Inflammatory Bowel Disease. | Gastro Hep Adv | 2026 | 41480406 | PubTator, text mining | PubMed |
| Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosis. | Kidney Int | 2026 | 41453490 | PubTator, text mining | PubMed |
| Clinical implications of Vasculitis associated with familial Mediterranean fever: a comparative study in childhood. | Mod Rheumatol | 2026 | 41439560 | PubTator, text mining | PubMed |
| Adalimumab-responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys-Dietz Syndrome. | DEN Open | 2026 | 41426201 | PubTator, text mining | PubMed |
| The Role of NLRP1, AIM2 and MEFV Inflammasomes in the High-Intensity Interval Training of Individuals With Obesity. | Immunology | 2026 | 41422827 | PubTator, text mining | PubMed |
| SpeckSeq enables high-throughput functional stratification of MEFV variants in autoinflammatory diseases. | J Exp Med | 2026 | 41335224 | PubTator, text mining | PubMed |
| Validity of the Eurofever/PRINTO genetic FMF classification criteria in FMF and PFAPA patients carrying non-confirmatory MEFV gene mutations. | Clin Rheumatol | 2026 | 41313543 | PubTator, text mining | PubMed |
| [An unusual cause for kidney transplantation]. | Inn Med (Heidelb) | 2026 | 41251715 | PubTator, text mining | PubMed |
| Exploring socio-economic, biochemical, and genetic factors influencing thyroid status in Indian school-going adolescents. | J Hum Genet | 2026 | 41249461 | PubTator, text mining | PubMed |
| Progressive increase of serum zinc level in a Pediatric patient with PSTPIP1- p.N236K mutation. | Clin Chim Acta | 2026 | 41072568 | PubTator, text mining | PubMed |
| Rare Coexistence of Hidradenitis Suppurativa and Hyper-IgD Syndrome With Homozygous MVK V377I and Compound Heterozygous MEFV (M680I/E148Q) Mutations. | Pediatr Dermatol | 2026 | 41047723 | PubTator, text mining | PubMed |
| Real-world Use of Canakinumab in Familial Mediterranean Fever and Other Autoinflammatory Disorders: A Medical Records Review Single-center Study From Turkey. | J Clin Rheumatol | 2026 | 41036629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4210/papers?page=8